Ex Parte ZACHARIAS et al - Page 8




         Appeal No. 2002-0741                                                       
         Application No. 08/935,348                                                 


         allegedly critical feature tends to rebut the argument of                  
         criticality, and (3) features that are merely preferred are not            
         critical.  While we appreciate that there are portions of                  
         appellants’ disclosure (e.g., page 13, line 12, through page 14,           
         line 7) that generally track the language of claims 1-12 with              
         respect to the properties of the adhesive recited in these                 
         claims, it is not apparent, and appellants have not argued, that           
         adhesives having the characteristics of claims 1-12 necessarily            
         possess the rheological property expressly stated in appellants’           
         specification as being critical to the present invention.  Based           
         on our reading of the specification in its entirety, and in                
         particular those portions noted above that very few adhesive               
         compositions are completely satisfactory for appellants’ purpose,          
         that the requirements for such adhesives are stringent, that               
         adhesives of the type used in appellants’ invention that are               
         applied to sensitive areas of the human body require further               
         special characteristics, and that the rheology property, tan               
         delta, described on page 24, lines 16-24, is critical to the               
         present invention, we conclude that the examiner was justified in          
         rejecting claims 1-12 under 35 U.S.C. § 112, first paragraph, as           
         not being supported by an enabling disclosure.                             


                                         8                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007